Inflammatory mediators in mastitis and lactation insufficiency.

Area of Science:

• Immunology
• Lactation Biology
• Cellular Biology

Background:

• Mastitis is a common lactation inflammatory disease reducing milk supply.
• Evidence suggests inflammation, not just bacterial infection, drives mastitis severity.
• Microbe-associated molecular patterns (MAMPs) and danger-associated molecular patterns (DAMPs) activate Toll-like receptors (TLRs), initiating inflammation.

Purpose of the Study:

• To challenge the notion that bacterial pathogens primarily cause mastitis.
• To explore the role of host inflammatory signaling pathways in mastitis.
• To propose alternative therapeutic strategies beyond antimicrobials.

Main Methods:

• Review of existing evidence on mastitis pathogenesis.
• Focus on Toll-like receptor 4 (TLR4) and nuclear factor kappa B (NFkB) signaling pathways.
• Analysis of risk factors such as perturbed milk flow, maternal stress, and genetics.

Main Results:

• TLR4/NFkB activation mediates mammary gland inflammation and systemic immune responses.
• NFkB activation can lead to epithelial cell apoptosis and reduced milk protein synthesis.
• Heightened host inflammatory signaling may interact with microbial factors to cause mastitis.

Conclusions:

• Mastitis pathogenesis may involve heightened host inflammatory responses, not solely bacterial infection.
• Therapeutic strategies targeting inflammatory pathways could be beneficial.
• This paradigm shift suggests new avenues for mastitis prevention and treatment.